Predictability of drug expenditures: An application using morbidity data

Health Economics

Volumn 17, Issue 1, 2008, Pages 119-126

  Garía Goñi, Manuel ^a   Ibern, Pere ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Clinical risk groups; Drug expenditure; Morbidity; Risk adjustment

Indexed keywords

DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG COST; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MORBIDITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPAIN; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DRUG COSTS; FEMALE; HEALTH STATUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RISK ASSESSMENT; SPAIN; STATE MEDICINE;

EID: 38949094556     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1238     Document Type: Article

References (19)

1. Ash AS, Byrne-Logan S. 1998. How well do models work? Predicting health care costs. Proceedings of the Section on Statistics in Epidemiology of the American Statistical Association, Dallas.
2. Ash AS, Ellis RP, Pope GC, Ayanian JZ, Bates DW, Burstin H, Iezzoni LI, MacKay E, Yu W. 2000. Using diagnoses to describe populations and predict costs. Health Care Financing Review 21: 7-28.
3. Coulson N, Stuart B. 1992. Persistence in the use of pharmaceuticals by the elderly: evidence from annual claims. Journal of Health Economics 11(3): 315-328.
4. Cumming RB, Knutson D, Cameron BA, Derrick B. 2002. A comparative analysis of claims-based methods of health risk assessment for commercial populations. Final Report to the Society of Actuaries.
5. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, O'Keeffe Rosetti MC. 2003. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Medical Care 41(1): 84-99.
6. García-Sempere A, Peiró S. 2001. Gasto farmacéutico en atención primaria: variables asociadas y asignación de presupuestos de farmacia por zonas de salud. Gaceta Sanitaria 15: 32-40.
7. Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, Gay JC. 2004. Clinical risk groups (CRGs). A classification system for risk-adjusted capitation-based payment and health care management. Medical Care 42: 81-90.
8. Lamers LM. 1999. Pharmacy costs groups: a risk-adjuster for capitation payment based on the use of prescribed drugs. Medical Care 37: 824-830.
9. Lamers LM, van Vliet RC. 2004. The pharmacy-based cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 68(1): 113-121.
10. OECD. 2006. OECD Health Data.
11. Powers CA, Meyer CM, Roebuck MC, Vaziri B. 2005. Predictive modeling of total healthcare costs using pharmacy claims data a comparison of alternative econometric cost modeling techniques. Medical care 43(11): 1065-1072.
12. Puig-Junoy J. 2004. Incentives and pharmaceutical reimbursement reforms in Spain. Health Policy 67: 149-165.
13. Rakovski C, Loveland SA, Anderson JJ, Berlowitz DR, Ash A. 2002. Evaluation of diagnosis-based risk adjustment among specific subgroups: can existing adjusters be improved by simple modifications? Health Services and Outcomes Research Methodology 3: 57-73.
14. Sales AE. Liu CF, Sloan KL, Malkin J, Fishman PA, Rosen AK, Loveland S, Paul Nichol W, Suzuki NT, Perrin E, Sharp ND, Todd-Stenberg J. 2003. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Medical Care 41(6): 753-760.
15. Stuart B, Ahern E, Rabatin V, Johnson L. 1991. Patterns of outpatient prescription drug use among the elderly: evidence from the PACE program. Health Care Financing Review 12(3): 61-72.
16. Van de Ven W, Ellis RP. 2000. Risk adjustment in competitive health plan markets. In Handbook in Health Economics, Culyer AJ, Newhouse JP (eds). Elsevier: Amsterdam, 755-845.
17. Wrobel MV, Doshi J, Stuart BC, Briesacher B. 2003. Predictability of prescription drug expenditures for medicare beneficiaries. Health Care Financing Review 25(2): 37-46.
18. Zhao Y, Ash AS, Ellis RP, Ayanian JZ, Pope GC, Bowen B, Weyuker L. 2005. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Medical Care 43(1): 34-43.
19. Zhao Y, Ellis RP, Ash AS, Calabrese D, Ayanian JZ, Slaughter JP, Weyuker L, Bowen B. 2001. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Services Research 36(6 Pt 2): 180-193.